Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer

  Free Subscription


27.11.2017

1 Arch Med Res
1 Biomed Res Int
1 Brachytherapy
1 Braz J Med Biol Res
1 Cancer Sci
1 Cell Cycle
1 Cureus
1 Emerg Infect Dis
1 Eur J Nucl Med Mol Imaging
2 Gynecol Oncol
1 Gynecol Oncol Rep
1 J Cancer
1 J Clin Pathol
1 J Med Virol
1 J Natl Cancer Inst
1 J Physiol Pharmacol
2 Oncol Lett
6 Oncotarget
1 Trials


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Med Res

  1. MARRERO-RODRIGUEZ D, la Cruz HA, Taniguchi-Ponciano K, Gomez-Virgilio L, et al
    Kruppel Like Factors Family Expression in Cervical Cancer Cells.
    Arch Med Res. 2017;48:314-322.
    PubMed     Text format     Abstract available


    Biomed Res Int

  2. WANG N, Li Y, Zhou J
    miR-31 Functions as an Oncomir Which Promotes Epithelial-Mesenchymal Transition via Regulating BAP1 in Cervical Cancer.
    Biomed Res Int. 2017;2017:6361420.
    PubMed     Text format     Abstract available


    Brachytherapy

  3. THIRUTHANEESWARAN N, Groom N, Lowe G, Bryant L, et al
    Focal boost to residual gross tumor volume in brachytherapy for cervical cancer-A feasibility study.
    Brachytherapy. 2017 Nov 15. pii: S1538-4721(17)30470.
    PubMed     Text format     Abstract available


    Braz J Med Biol Res

  4. DE ALMEIDA VH, de Melo AC, Meira DD, Pires AC, et al
    Radiotherapy modulates expression of EGFR, ERCC1 and p53 in cervical cancer.
    Braz J Med Biol Res. 2017;51:e6822.
    PubMed     Text format     Abstract available


    Cancer Sci

  5. TAKAKURA M, Matsumoto T, Nakamura M, Mizumoto Y, et al
    Detection of CTCs in cervical cancer using a conditionally replicative adenovirus targeting telomerase-positive cells.
    Cancer Sci. 2017 Nov 19. doi: 10.1111/cas.13449.
    PubMed     Text format     Abstract available


    Cell Cycle

  6. ZHANG Q, Qiao L, Wang X, Ding C, et al
    UHRF1 epigenetically down-regulates UbcH8 to inhibit apoptosis in cervical cancer cells.
    Cell Cycle. 2017 Nov 20:1-22. doi: 10.1080/15384101.2017.1403686.
    PubMed     Text format     Abstract available


    Cureus

  7. COHEN J, Harper A, Nichols EM, Rao GG, et al
    Barriers to Timely Completion of Radiation Therapy in Patients with Cervical Cancer in an Urban Tertiary Care Center.
    Cureus. 2017;9:e1681.
    PubMed     Text format     Abstract available


    Emerg Infect Dis

  8. SENKOMAGO V, Duran D, Loharikar A, Hyde TB, et al
    CDC Activities for Improving Implementation of Human Papillomavirus Vaccination, Cervical Cancer Screening, and Surveillance Worldwide.
    Emerg Infect Dis. 2017;23.
    PubMed     Text format     Abstract available


    Eur J Nucl Med Mol Imaging

  9. SU TP, Lin G, Huang YT, Liu FY, et al
    Comparison of positron emission tomography/computed tomography and magnetic resonance imaging for posttherapy evaluation in patients with advanced cervical cancer receiving definitive concurrent chemoradiotherapy.
    Eur J Nucl Med Mol Imaging. 2017 Nov 20. doi: 10.1007/s00259-017-3884.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  10. CHOLLI P, Bradford L, Manga S, Nulah K, et al
    Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
    Gynecol Oncol. 2017 Nov 15. pii: S0090-8258(17)31497.
    PubMed     Text format     Abstract available

  11. CHONG GO, Lee YH, Han HS, Lee HJ, et al
    Prognostic value of pre-treatment human papilloma virus DNA status in cervical cancer.
    Gynecol Oncol. 2017 Nov 15. pii: S0090-8258(17)31498.
    PubMed     Text format     Abstract available


    Gynecol Oncol Rep

  12. MENON S, Rossi R, Harmon SG, Mabeya H, et al
    Public health approach to prevent cervical cancer in HIV-infected women in Kenya: Issues to consider in the design of prevention programs.
    Gynecol Oncol Rep. 2017;22:82-88.
    PubMed     Text format     Abstract available


    J Cancer

  13. CHEN XJ, Han LF, Wu XG, Wei WF, et al
    Clinical Significance of CD163+ and CD68+ Tumor-associated Macrophages in High-risk HPV-related Cervical Cancer.
    J Cancer. 2017;8:3868-3875.
    PubMed     Text format     Abstract available


    J Clin Pathol

  14. CHETTY R
    70 years of the JCP-highly cited papers: The causal relation between human papillomavirus and cervical cancer.
    J Clin Pathol. 2017;70:997.
    PubMed     Text format    


    J Med Virol

  15. TSAKOGIANNIS D, Moschonas GD, Bella E, Kyriakopoulou Z, et al
    Association of p16 (CDKN2A) polymorphisms with the development of HPV16-related precancerous lesions and cervical cancer in the Greek population.
    J Med Virol. 2017 Nov 23. doi: 10.1002/jmv.24996.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  16. AZVOLINSKY A
    Screening Guideline for Cervical Cancer Recommends Against Human Papillomavirus-Pap Cotesting.
    J Natl Cancer Inst. 2017 Nov 15. doi: 10.1093.
    PubMed     Text format    


    J Physiol Pharmacol

  17. WAGNER W, Kania KD, Blauz A, Ciszewski WM, et al
    The lactate receptor (HCAR1/GPR81) contributes to doxorubicin chemoresistance via ABCB1 transporter up-regulation in human cervical cancer HeLa cells.
    J Physiol Pharmacol. 2017;68:555-564.
    PubMed     Text format     Abstract available


    Oncol Lett

  18. WANG J, Yue X
    Role and importance of the expression of transcription factor FOXC2 in cervical cancer.
    Oncol Lett. 2017;14:6627-6631.
    PubMed     Text format     Abstract available

  19. LIANG S, Ju X, Zhou Y, Chen Y, et al
    Downregulation of eukaryotic initiation factor 4A1 improves radiosensitivity by delaying DNA double strand break repair in cervical cancer.
    Oncol Lett. 2017;14:6976-6982.
    PubMed     Text format     Abstract available


    Oncotarget

  20. LIN SM, Ku HY, Chang TC, Liu TW, et al
    The prognostic impact of overall treatment time on disease outcome in uterine cervical cancer patients treated primarily with concomitant chemoradiotherapy: a nationwide Taiwanese cohort study.
    Oncotarget. 2017;8:85203-85213.
    PubMed     Text format     Abstract available

  21. SCHREVEL M, Corver WE, Vegter ME, Ter Haar NT, et al
    L1 cell adhesion molecule (L1CAM) is a strong predictor for locoregional recurrences in cervical cancer.
    Oncotarget. 2017;8:87568-87581.
    PubMed     Text format     Abstract available

  22. CHUANYIN L, Xiaona W, Zhiling Y, Yu Z, et al
    The association between polymorphisms in microRNA genes and cervical cancer in a Chinese Han population.
    Oncotarget. 2017;8:87914-87927.
    PubMed     Text format     Abstract available

  23. CHONG GO, Lee WK, Jeong SY, Park SH, et al
    Prognostic value of intratumoral metabolic heterogeneity on F-18 fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced cervical cancer patients treated with concurrent chemoradiotherapy.
    Oncotarget. 2017;8:90402-90412.
    PubMed     Text format     Abstract available

  24. ZHANG Y, Shi T, Yin S, Ma S, et al
    An improved nerve-sparing radical hysterectomy technique for cervical cancer using the paravesico-vaginal space as a new surgical landmark.
    Oncotarget. 2017;8:90413-90420.
    PubMed     Text format     Abstract available

  25. GAO YL, Zhang MY, Xu B, Han LJ, et al
    Circular RNA expression profiles reveal that hsa_circ_0018289 is up-regulated in cervical cancer and promotes the tumorigenesis.
    Oncotarget. 2017;8:86625-86633.
    PubMed     Text format     Abstract available


    Trials

  26. LINDE DS, Andersen MS, Mwaiselage JD, Manongi R, et al
    Text messages to increase attendance to follow-up cervical cancer screening appointments among HPV-positive Tanzanian women (Connected2Care): study protocol for a randomised controlled trial.
    Trials. 2017;18:555.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: